List of SBIR/STTR awards granted to POP Biotechnologies
POP BiotechnologiesName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to POP Biotechnologies in February, 2020 for $223,797.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AI149954-01 | Phase I | 223,797 | February 10, 2020 | |||||||
A STTR Phase II contract was awarded to POP Biotechnologies in September, 2022 for $1,001,404.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42CA243954-02 | Phase II | 1,001,404 | September 8, 2022 | |||||||
A STTR Phase I contract was awarded to POP Biotechnologies in April, 2020 for $399,917.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41CA243954-01A1 | Phase I | 399,917 | April 6, 2020 | |||||||
A SBIR Phase I contract was awarded to POP Biotechnologies in July, 2021 for $299,991.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI165089-01 | Phase I | 299,991 | July 9, 2021 | |||||||
A SBIR Phase I contract was awarded to POP Biotechnologies in September, 2018 for $279,205.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA228707-01A1 | Phase I | 279,205 | September 6, 2018 | |||||||
A SBIR Phase I contract was awarded to POP Biotechnologies for $599,897.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93019C00011 | Phase I | 599,897 | ||||||||
A STTR Phase I contract was awarded to POP Biotechnologies in September, 2023 for $248,855.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AG082620-01 | Phase I | 248,855 | September 15, 2023 | |||||||
A SBIR Phase I contract was awarded to POP Biotechnologies for $599,806.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93023C00031 | Phase I | 599,806 |
